| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |